These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 15969661

  • 1. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].
    Bousquet J, Gaugris S, Kocevar VS, Zhang Q, Yin DD, Polos PG, Bjermer L.
    Clin Exp Allergy; 2005 Jun; 35(6):723-7. PubMed ID: 15969661
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 3. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [Abstract] [Full Text] [Related]

  • 6. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.
    Price DB, Swern A, Tozzi CA, Philip G, Polos P.
    Allergy; 2006 Jun; 61(6):737-42. PubMed ID: 16677244
    [Abstract] [Full Text] [Related]

  • 7. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
    O'Connor RD, Gilmore AS, Manjunath R, Stanford RH, Legorreta AP, Jhingran PM.
    Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME, Diette GB, Chang CL, Stephenson JJ, Sajjan SG, Fan T, Allen-Ramey FC.
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [Abstract] [Full Text] [Related]

  • 11. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [Abstract] [Full Text] [Related]

  • 12. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC, Anstatt DT, Sajjan SG, Markson LE.
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [Abstract] [Full Text] [Related]

  • 13. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM.
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [Abstract] [Full Text] [Related]

  • 14. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 15. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC, Duong PT, Riedel AA, Markson LE, Weiss KB.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [Abstract] [Full Text] [Related]

  • 16. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis.
    Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D.
    Pediatrics; 2005 Jan; 115(1):129-34. PubMed ID: 15629992
    [Abstract] [Full Text] [Related]

  • 17. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

  • 18. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 19. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults.
    Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M.
    Clin Exp Allergy; 2005 Mar; 35(3):282-7. PubMed ID: 15784104
    [Abstract] [Full Text] [Related]

  • 20. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast.
    Orsini L, Limpa-Amara S, Crown WH, Stanford RH, Kamal K.
    Ann Allergy Asthma Immunol; 2004 May; 92(5):523-9. PubMed ID: 15191020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.